Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device Legal Issues

Judge Weighs $42 Million Orthofix Settlement With Feds

This article was originally published in The Gray Sheet

  • News

Executive Summary

Orthofix pleaded guilty to the felony of obstructing a federal audit and also has settled civil charges with the federal government. But the settlement will not be final until it is approved by a federal judge, who postponed his decision last week.

You may also be interested in...



News In Brief

Judge rejects Orthofix settlement with feds. ConvaTec purchases catheter-provider 180 Medical. Cook announces new product division. More news briefs.

News In Brief

Orthofix settles foreign bribery charges. Cardiosolutions wins $8 million investment for mitral valve technology. OraSure plans $75 million stock offering. More news in brief.

News In Brief

LabCorp buys Medtox Scientific. Halma buys SunTech. FCC outlines wireless health plan. More briefs.

Table

View full table

Topics

Tags:
Medical Device Legal Issues
Latest Headlines

WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency

Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages

Gene Therapy: Pediatric Development Could Start Sooner Than Sponsors Think – FDA OTP Director

Puberty Blockers: FDA's Califf Asked If REMS, Boxed Warning Against Off-Label Use In The Works

See All
UsernamePublicRestriction

Register

MT031428

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By